Pulmonary hemodynamics as predictors of mortality in patients awaiting lung transplantation

被引:20
作者
Selimovic, Nedim [1 ]
Andersson, Bert [1 ]
Bergh, Claes-Hakan [1 ]
Martensson, Gunnar [2 ]
Nilsson, Folke [3 ]
Bech-Hanssen, Odd [4 ]
Rundqvist, Bengt [1 ]
机构
[1] Sahlgrens Univ Hosp, Dept Cardiol, SE-41345 Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Dept Resp Med, SE-41345 Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Thorac Surg, SE-41345 Gothenburg, Sweden
[4] Sahlgrens Univ Hosp, Dept Clin Physiol, SE-41345 Gothenburg, Sweden
关键词
lung function tests; lung transplantation; mortality on the waiting list; pulmonary hypertension; pulmonary vascular resistance;
D O I
10.1111/j.1432-2277.2007.00605.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Lung transplantation (LTx) is a therapeutic option for patients with end-stage lung disease. However, the mortality rate of patients on the waiting list is high. The purpose of this study was to examine the prognostic value of cardio-pulmonary hemodynamics for death in patients awaiting LTx. Retrospectively, 177 patients with advanced lung disease accepted for LTx at Sahlgrenska University Hospital from January 1990 through December 2003 were studied. Patient demographics, pulmonary function tests, gas exchange and hemodynamic variables were included in the analysis. Death while awaiting LTx was the primary endpoint for all analyses. Mean age was 49 9 years. Main diagnoses were alpha 1 antitrypsin deficiency (n = 56), chronic obstructive pulmonary disease (n = 61), cystic fibrosis (n = 14) and interstitial lung disease (n = 46). Thirty patients died (17%). LTx was performed in 143 cases. By univariate analyses, forced vital capacity (FVC) % of predicted, pulmonary vascular resistance (PVR) and diagnosis were associated with risk for death. In multivariate analysis PVR (HR, 1.22; 95% Cl, 1.06-1.41; P = 0.006) and FVC% of predicted (HR, 0.97; 95% CI, 0.94-0.99; P = 0.01) were independently associated with death. Patients with increased PVR and a lower FVC % of predicted awaiting LTx should be considered for a higher organ allocation priority. Assessment of pulmonary hemodynamics needs to be considered during evaluation for LTx.
引用
收藏
页码:314 / 319
页数:6
相关论文
共 23 条
[1]   Severe pulmonary hypertension and chronic obstructive pulmonary disease [J].
Chaouat, A ;
Bugnet, AS ;
Kadaoui, N ;
Schott, R ;
Enache, I ;
Ducoloné, A ;
Ehrhart, M ;
Kessler, R ;
Weitzenblum, E .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (02) :189-194
[2]  
Chaparro C, 1997, J HEART LUNG TRANSPL, V16, P511
[3]   Assessment of survival benefit after lung transplantation by patient diagnosis [J].
Charman, SC ;
Sharples, LD ;
McNeil, KD ;
Wallwork, J .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (02) :226-232
[4]   Lung transplant waiting list: Differential outcome of type of end-stage lung disease, one year after registration [J].
De Meester, J ;
Smits, JMA ;
Persijn, GG ;
Haverich, A .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (06) :563-571
[5]  
Egan T. M., 2001, Journal of Heart and Lung Transplantation, V20, P242, DOI 10.1016/S1053-2498(00)00547-7
[6]  
Harari S, 1997, J HEART LUNG TRANSPL, V16, P460
[7]   Update in pulmonary hypertension 2005 [J].
Hoeper, MM ;
Rubin, LJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (05) :499-505
[8]   Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease [J].
Hosenpud, JD ;
Bennett, LE ;
Keck, BM ;
Edwards, EB ;
Novick, RJ .
LANCET, 1998, 351 (9095) :24-27
[9]   Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model [J].
King, TE ;
Tooze, JA ;
Schwarz, MI ;
Brown, KR ;
Cherniack, RM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (07) :1171-1181
[10]   Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis [J].
Lettieri, CJ ;
Nathan, SD ;
Barnett, SD ;
Ahmad, S ;
Shorr, AF .
CHEST, 2006, 129 (03) :746-752